Patent · US Active

Anti-CD38 antibodies

US10494444B2 · kind B2 · utility

5Cited by

7References

10Claims

0Family size

Assignee

Takeda Pharmaceutical Company Limited · JP

Inventors

Kathleen Ann Elias · San Francisco, US
Gregory Landes · San Bruno, US
Shweta Singh · Fremont, US
Wouter Korver · South San Francisco, US
Andrew W. Drake · Mountain View, US
Mary Haak-Frendscho · Madison, US
Gyorgy Pal Snell · South San Francisco, US
Vinay Bhaskar · South San Francisco, US

Key dates

Filing date	Sep 13, 2017
Grant date	Dec 3, 2019
Priority date	—
Expiry date	Sep 13, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Isolated antibodies that bind to human CD38 and cynomolgus CD38 are disclosed. Also disclosed are pharmaceutical compositions comprising the disclosed antibodies, and therapeutic and diagnostic methods for using the disclosed antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.